Senior insider sale
Chief Financial Officer at ENTRADA THERAPEUTICS, INC. — senior position signals high conviction
$445.2K
35.62K shares
What this filing means
WENTWORTH KORY JAMES plans to sell 35.62K shares of ENTRADA THERAPEUTICS, INC. valued at approximately $445.2K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 4/1/2026ACC: 0001950047-26-003138
Officer· Chief Financial Officer
Since Oct 2021
35.62K
Shares to sell
$445.2K
Approx. market value
2.50K
Acquired (3 months)
1
Planned
5 completed
Securities Acquired — Last 3 Months1
Previously Exercised Stock Options
Cash
3/15/2024
2.50KTotal acquired2.50K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/15/2024 | Previously Exercised Stock Options Cash | 2.50K | — |
| Total | 2.50K | ||
Planned & Completed Dispositions6
Completed
—Completed
Units to sell
11.39K
Market value
$148.2K
3/10/2026
—Completed
Units to sell
5.09K
Market value
$66.2K
3/9/2026
—Completed
Units to sell
7.99K
Market value
$97.9K
3/4/2026
—Completed
Units to sell
5.71K
Market value
$67.2K
3/3/2026
—Completed
Units to sell
2.94K
Market value
$34.3K
3/2/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
2.50K
Market value
$31.6K
4/1/2026
Total
Units
35.62K
Value
$445.2K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
3/10/2026 | 11.39K | $148.2K | — | Completed |
3/9/2026 | 5.09K | $66.2K | — | Completed |
3/4/2026 | 7.99K | $97.9K | — | Completed |
3/3/2026 | 5.71K | $67.2K | — | Completed |
3/2/2026 | 2.94K | $34.3K | — | Completed |
| Planned — Approximate Date | ||||
4/1/2026 | 2.50K | $31.6K | NASDAQ | Planned |
| Total | 35.62K | $445.2K | ||